Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2245
https://www.valueinhealthjournal.com/article/S1098-3015(16)33611-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2133
First Page :
A739
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33611-7&doi=10.1016/j.jval.2016.09.2245